"Welcome to Midwest Allergy Sinus Asthma, SC, an allergist office with locations in Normal and Springfield, Illinois. The practice’s goal is to provide you with exceptional care through the use of up-to-date technology and advanced medical knowledge. Midwest Allergy Sinus Asthma also believes in fair, compassionate, personalized, and respectful health care for people of all ages, gender expressions, and walks of life. To them, nothing matters more than the health of the community. For your convenience, the practice offers easy appointment scheduling, with flexible and accessible time slots. The practice offers services such as environmental and food allergy testing, allergy action plans, asthma care, sinusitis treatment, immunology, & more."

During the past decade, Midwest Allergy Sinus Asthma, SC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midwest Allergy Sinus Asthma, SC" #1 sponsor was "Pfizer" with 4 trials, followed by "AnaptysBio, Inc." with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "Celldex Therapeutics" with 1 trials sponsored and "Optinose US Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Midwest Allergy Sinus Asthma, SC" are "Dermatitis, Atopic" (3 trials), "Atopic Dermatitis" (2 trials), "Dermatitis" (2 trials), "Eczema" (2 trials) and "Genetic Diseases, Inborn" (2 trials). Many other conditions were trialed in "Midwest Allergy Sinus Asthma, SC" in a lesser frequency.

Most popular intervention types in "Midwest Allergy Sinus Asthma, SC" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "Ruxolitinib cream" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Allergy Sinus Asthma, SC" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Midwest Allergy Sinus Asthma, SC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Midwest Allergy Sinus Asthma, SC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Allergy Sinus Asthma, SC, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".